Rapid quality control test SC-2047-25

for antibodiesfor tramadolimmunochromatographic

SCREEN 1 TRAMADOLO One Step Drug Test Card REF: SC-2047-25 The Screen 1 Tramadol rapid test (TML) (Urine) is a rapid immunochromatographic test for the qualitative detection of Tramadol in human urine at a concentration of 100 ng / mL. It is a clinical exam intended for use by health professionals, including those in outpatient clinics. This test will identify other related compounds, please refer to the Analytical Specificity table in this package insert. Tramadol (TML) is a quasi-narcotic analgesic used in the treatment of moderate to severe pain. It is a synthetic analogue of codeine, but has a low binding affinity for μ-opioid receptors. High doses of Tramadol can induce tolerance and psychological dependence and lead to abuse. Tramadol is extensively metabolized after oral intake. About 30% of the dose is excreted in the urine as an unchanged drug, while 60% of the dose is excreted as metabolites. The main routes appear to be N- and O-demethylation, glucuronidation or sulfation in the liver. The TML (Urine) rapid panel test is a rapid urine control test that can be performed without the use of instrumentation. The test uses a monoclonal antibody to selectively detect high levels of Tramadol in urine. The TML (Urine) rapid panel test provides a positive result when Tramadol in urine exceeds 100 ng / mL. Currently, the Administration for Substances of Abuse and Mental Health Services (SAMHSA) has not provided a recommended screening threshold for Tramadol positive samples. (The 120ml urine container is supplied separately, you can buy it on the “Accessories” page).